Antti Nieminen

Antti Nieminen currently serves as Deputy CEO at 3PBIOVIAN since February 2024 and as a Board Member for Finnish bioindustries since June 2022. Since February 2003, Antti has been the CEO of Biovian, a Contract Development and Manufacturing Organization (CDMO) specializing in GMP manufacturing of biopharmaceuticals, and has also held roles as Director of Business Development and Projects and Project Manager at the same company. Additionally, Antti has been a Board Member at Hidex since June 2018 and holds a Master of Science (M.Sc.) degree in Biotechnology from the University of Turku, obtained between 1996 and 2001.